Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant ChemotherapyRoland Seiler, Peter C. Black, H.A.D.M. Ashab et al.|European Urology|2017Cited by 793
Recurrence mechanisms of non-muscle-invasive bladder cancer — a clinical perspectiveJeremy Yuen‐Chun Teoh, Marek Babjuk, Ashish M. Kamat et al.|Nature Reviews Urology|2022Cited by 196
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†J. Alfred Witjes, Donna E. Hansel, Alberto Briganti et al.|European Urology|2019Cited by 191
Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate CancerGillian Vandekerkhove, Alexander W. Wyatt, Werner J. Struss et al.|European Urology|2019Cited by 183
EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines CommitteesAlan Horwich, Donna E. Hansel, Marek Babjuk et al.|Annals of Oncology|2019Cited by 182